InvestorsHub Logo
Followers 213
Posts 6078
Boards Moderated 1
Alias Born 01/07/2015

Re: JJAAMMAANN post# 11197

Wednesday, 02/22/2017 8:15:41 AM

Wednesday, February 22, 2017 8:15:41 AM

Post# of 232951
They announced in a press release on January 11th that it had been filed.

http://www.cytodyn.com/media/press-releases/detail/251/cytodyn-files-for-breakthrough-therapy-designation-with-the


VANCOUVER, Washington, Jan. 11, 2017 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new therapies for combating human immunodeficiency virus (HIV) infection, today announced the Company filed a request for Breakthrough Therapy Designation with the FDA for PRO 140 as a treatment for HIV-1 infection in treatment-experienced patients with virologic failure.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News